Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization
Eva Randarova et al.
ACTA BIOMATERIALIA (2020)
HPMA-based star polymer biomaterials with tuneable structure and biodegradability tailored for advanced drug delivery to solid tumours
Libor Kostka et al.
BIOMATERIALS (2020)
Semi-quantitative Determination of Protein Expression Using Immunohistochemistry Staining and Analysis: An Integrated Protocol
Alexandra R. Crowe et al.
BIO-PROTOCOL (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Cardiac and renal complications of carfilzomib in patients with multiple myeloma
Meletios A. Dimopoulos et al.
BLOOD ADVANCES (2017)
HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases
Haruhiko Dozono et al.
TARGETED ONCOLOGY (2016)
Factorial design studies of antiretroviral drug-loaded stealth liposomal injectable: PEGylation, lyophilization and pharmacokinetic studies
Beeravelli Sudhakar et al.
APPLIED NANOSCIENCE (2016)
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
Karel Ulbrich et al.
CHEMICAL REVIEWS (2016)
Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors
Eva Koziolova et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
Arun K. Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Micelle-forming HPMA copolymer conjugates of ritonavir bound via a pH-sensitive spacer with improved cellular uptake designed for enhanced tumor accumulation
E. Koziolova et al.
JOURNAL OF MATERIALS CHEMISTRY B (2016)
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Edgar Perez-Herrero et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
A Novel ImageJ Macro for Automated Cell Death Quantitation in the Retina
Daniel E. Maidana et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Synthesis of Poly[N-(2-hydroxypropyl)methacrylamide] Conjugates of Inhibitors of the ABC Transporter That Overcome Multidrug Resistance in Doxorubicin-Resistant P388 Cells in Vitro
V. Subr et al.
BIOMACROMOLECULES (2014)
Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
Ho-June Lee et al.
CANCER CELL (2014)
HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-kappa B pathway
Ryusho Kariya et al.
CANCER LETTERS (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
Alexei F. Kisselev et al.
CHEMISTRY & BIOLOGY (2012)
The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo
Camille Bono et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity
Tomas Etrych et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
Jitka Fucikova et al.
CANCER RESEARCH (2011)
Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors
Arun K. Mankan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Hiroshi Maeda
BIOCONJUGATE CHEMISTRY (2010)
N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation
Petr Chytil et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Polymer therapeutics: Clinical applications and challenges for development Preface
Maria J. Vicent et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Stereogradient Polymers Formed by Controlled/Living Radical Polymerization of Bulky Methacrylate Monomers
Kenji Ishitake et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Heehyoung Lee et al.
CANCER CELL (2009)
In Vivo Expansion of Activated Naive CD8+ T Cells and NK Cells Driven by Complexes of IL-2 and Anti-IL-2 Monoclonal Antibody As Novel Approach of Cancer Immunotherapy
Jakub Tomala et al.
JOURNAL OF IMMUNOLOGY (2009)
Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells
Sanjeev Kumar et al.
MOLECULAR CANCER (2009)
Anti-HIV drugs for cancer therapeutics: back to the future?
Warren A. Chow et al.
LANCET ONCOLOGY (2009)
CD4+ Regulatory T Cells Control TH17 Responses in a Stat3-Dependent Manner
Ashutosh Chaudhry et al.
SCIENCE (2009)
Nelfinavir, a lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo
JoellJ. Gills et al.
CLINICAL CANCER RESEARCH (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Evaluation of antitumoral properties of the protease inhibitor indinavir in a murine model of hepatocarcinoma
V Esposito et al.
CLINICAL CANCER RESEARCH (2006)
Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer
A Srirangam et al.
CLINICAL CANCER RESEARCH (2006)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Finding new tricks for old drugs: An efficient route for public-sector drug discovery
KA O'Connor et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling
Y Yang et al.
CANCER SCIENCE (2005)
Reversible addition-fragmentation chain transfer polymerization: End group modification for functionalized polymers and chain transfer agent recovery
S Perrier et al.
MACROMOLECULES (2005)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
HIV-1 protease inhibitor, ritonavir:: A potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo
T Ikezoe et al.
CANCER RESEARCH (2004)
Starlike vs. classic macromolecular prodrugs:: Two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs
M Jelínková et al.
PHARMACEUTICAL RESEARCH (2003)
Enantioselective synthesis of sabina ketone
M Barberis et al.
TETRAHEDRON LETTERS (2003)
Inhibition of proteasome function induced apoptosis in gastric cancer
XM Fan et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage:: synthesis and preliminary in vitro and in vivo biological properties
T Etrych et al.
JOURNAL OF CONTROLLED RELEASE (2001)
The role of STATs in transcriptional control and their impact on cellular function
J Bromberg et al.
ONCOGENE (2000)
Share Paper
